                         SEQUENCE LISTING

<110>  Technische Universiteit Eindhoven
 
<120>  Peptides for use in the treatment of cholerae

<130>  patent

<160>  62    

<170>  PatentIn version 3.5

<210>  1
<211>  196
<212>  PRT
<213>  Marinomonas primoryensis

<400>  1

Glu Glu Phe Glu Val Ser Glu Ile Ala Ala Ser Trp Val Ser Tyr Thr 
1               5                   10                  15      


His Gly Glu Ser Val Thr Thr Phe Asp Gly Thr Ser Asp Leu Gly Gly 
            20                  25                  30          


Val Asp Asn Asp Ser Ala Lys Asp Gln Ile Arg Trp Gly Asn Pro Ala 
        35                  40                  45              


Glu Ser Lys Gln Ser Gly Tyr Gly Phe Ile Asp Asn Asp Ser Asn Leu 
    50                  55                  60                  


Glu Gly Arg Phe Asp Leu Asn Gln Asp Ile Ser Val Gly Thr Phe Thr 
65                  70                  75                  80  


His Tyr Asn Tyr Pro Val Tyr Ser Gly Gly Ala Ile Thr Ser Ala Glu 
                85                  90                  95      


Met Ser Val Glu Phe Ser Val Leu Asp His Leu Gly Val Ser Thr Pro 
            100                 105                 110         


Val Thr Leu Thr Val Asn Phe Asp His Asn Glu Thr Pro Asn Thr Asn 
        115                 120                 125             


Asp Val Asn Ala Ser Arg Asp Ile Val Thr Val Gln Asn Thr His Val 
    130                 135                 140                 


Thr Phe Glu Arg Asp Gly Asp Ile Tyr Thr Val Gln Ile Val Gly Phe 
145                 150                 155                 160 


Arg Glu Val Gly Asn Pro Asp Gly Glu Val Val Thr Ser Ile Tyr Thr 
                165                 170                 175     


Asn Glu Asn Ala Ala Thr Ser Tyr Glu Leu Val Val Arg Val Val Glu 
            180                 185                 190         


Gly Asp Gly Tyr 
        195     


<210>  2
<211>  196
<212>  PRT
<213>  Vibrio cholerae

<400>  2

Asp Ser Phe Thr Val Ser Gly Val Val Ala Asn Trp Thr Ser Trp Ser 
1               5                   10                  15      


Asn Gly Thr Asn Val Thr Thr Phe Asp Gly Thr Asn Ala Pro Asn Gly 
            20                  25                  30          


Gly Gly Leu Asp Asn Asp Ser Gly Lys Asp Gln Ile Arg Trp Gly Gln 
        35                  40                  45              


Pro Ala Ser Ser Tyr Ser Ser Gly Tyr Gly Phe Ile Asp Asn Asp Ser 
    50                  55                  60                  


Ala Leu Asn Gly Glu Phe Ala Leu Asn Gln Asp Ile Ile Leu Gly Thr 
65                  70                  75                  80  


Phe Thr His Tyr Asn Tyr Pro Val Tyr Ser Gly Gly Ala Ile Thr Ser 
                85                  90                  95      


Ala Ser Met Asp Val Ala Phe Ser Val Thr Asp Ala His Gly Val Leu 
            100                 105                 110         


Thr Pro Val Thr Leu Lys Leu Asn Phe Asp His Asn Glu Thr Pro Asn 
        115                 120                 125             


Thr Asn Asn Pro Glu Ala Ser Lys Asp Ile Ile Lys Val Gly Asn Thr 
    130                 135                 140                 


Asn Val Thr Phe Glu Asn Ala Gly Ala Leu Tyr Thr Leu Gln Val Ile 
145                 150                 155                 160 


Gly Phe Arg Ile Pro Gly Thr Asn Gln Ile Val Thr Glu Ile Arg Thr 
                165                 170                 175     


Gly Glu Asn Ala Thr Asn Ser Tyr Glu Leu Val Val Arg Val Gly Pro 
            180                 185                 190         


Gly Glu Gly Tyr 
        195     


<210>  3
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  beta alanine with FITC label

<400>  3

Ala Gly Pro Asp Ser Asp 
1               5       


<210>  4
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  beta alanine with FITC label

<400>  4

Ala Asp Ser Thr Asp 
1               5   


<210>  5
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  beta alanine with FITC label

<400>  5

Ala Gly Pro Asp Asp 
1               5   


<210>  6
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  beta alanine with FITC label

<400>  6

Ala Asp Ser Thr Pro Asp 
1               5       


<210>  7
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 4 and figure 5


<220>
<221>  misc_feature
<222>  (4)..(4)
<223>  Xaa can be any naturally occurring amino acid

<400>  7

Ala Gly Ala Xaa Asp 
1               5   


<210>  8
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 4 and figure 5

<400>  8

Ala Gly Ala Thr Asp 
1               5   


<210>  9
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 4 and figure 5


<220>
<221>  misc_feature
<222>  (3)..(3)
<223>  Xaa can be any naturally occurring amino acid

<400>  9

Ala Gly Xaa Thr Asp 
1               5   


<210>  10
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 4 and figure 5

<400>  10

Ala Gly Trp Thr Asp 
1               5   


<210>  11
<211>  201
<212>  PRT
<213>  Vibrio cholerae

<400>  11

Val Asp Ile Val Ala Asp Ser Phe Thr Val Ser Gly Val Val Ala Asn 
1               5                   10                  15      


Trp Thr Ser Trp Ser Asn Gly Thr Asn Val Thr Thr Phe Asp Gly Thr 
            20                  25                  30          


Asn Ala Pro Asn Gly Gly Gly Leu Asp Asn Asp Ser Gly Lys Asp Gln 
        35                  40                  45              


Ile Arg Trp Gly Gln Pro Ala Ser Ser Tyr Ser Ser Gly Tyr Gly Phe 
    50                  55                  60                  


Ile Asp Asn Asp Ser Ala Leu Asn Gly Glu Phe Ala Leu Asn Gln Asp 
65                  70                  75                  80  


Ile Ile Leu Gly Thr Phe Thr His Tyr Asn Tyr Pro Val Tyr Ser Gly 
                85                  90                  95      


Gly Ala Ile Thr Ser Ala Ser Met Asp Val Ala Phe Ser Val Thr Asp 
            100                 105                 110         


Ala His Gly Val Leu Thr Pro Val Thr Leu Lys Leu Asn Phe Asp His 
        115                 120                 125             


Asn Glu Thr Pro Asn Thr Asn Asn Pro Glu Ala Ser Lys Asp Ile Ile 
    130                 135                 140                 


Lys Val Gly Asn Thr Asn Val Thr Phe Glu Asn Ala Gly Ala Leu Tyr 
145                 150                 155                 160 


Thr Leu Gln Val Ile Gly Phe Arg Ile Pro Gly Thr Asn Gln Ile Val 
                165                 170                 175     


Thr Glu Ile Arg Thr Gly Glu Asn Ala Thr Asn Ser Tyr Glu Leu Val 
            180                 185                 190         


Val Arg Val Gly Pro Gly Glu Gly Tyr 
        195                 200     


<210>  12
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 4 and figure 5

<400>  12

Ala Gly Tyr Thr Asp 
1               5   


<210>  13
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 4 and figure 5

<400>  13

Ala Gly Phe Thr Asp 
1               5   


<210>  14
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 3

<400>  14

Ser Ala Glu Arg Arg Asn Ser Ile Leu Thr Glu Thr Leu 
1               5                   10              


<210>  15
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 3

<400>  15

Glu Thr Leu His Arg Phe Ser Leu Glu Gly Asp Ala Pro 
1               5                   10              


<210>  16
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 3

<400>  16

Gly Glu Lys Arg Lys Asn Ser Ile Leu Asn Pro Ile Asn 
1               5                   10              


<210>  17
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 3

<400>  17

Asn Ser Ile Arg Lys Phe Ser Ile Val Gln Lys Thr Pro 
1               5                   10              


<210>  18
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 3

<400>  18

Pro Leu Glu Arg Leu Leu Ser Leu Val Pro Asp Ser Glu 
1               5                   10              


<210>  19
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 3

<400>  19

Gln Ala Arg Arg Arg Gln Ser Val Leu Asn Leu Met Thr 
1               5                   10              


<210>  20
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 3

<400>  20

Ala Ser Thr Arg Lys Val Ser Leu Ala Pro Gln Ala Asn 
1               5                   10              


<210>  21
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 3

<400>  21

Ile Tyr Ser Arg Arg Leu Ser Gln Glu Thr Gly Leu Glu 
1               5                   10              


<210>  22
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 3

<400>  22

Glu Gly Thr Ala Ser Gly Ser Asp Gly Asn Phe Ser Glu 
1               5                   10              


<210>  23
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 3

<400>  23

Leu Gln Arg His Ser Asn Ser Leu Gly Pro Ile Phe Asp 
1               5                   10              


<210>  24
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 3

<400>  24

His Met Arg His Ser Asp Ser Ile Ser Ser Leu Ala Ser 
1               5                   10              


<210>  25
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 3

<400>  25

Arg His Lys Lys Leu Met Phe Lys Thr Glu Gly Pro Asp Ser Asp 
1               5                   10                  15  


<210>  26
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 4 and figure 5

<400>  26

Ala Gly Ala Ala Asp 
1               5   


<210>  27
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 4 and figure 5

<400>  27

Ala Gly Ala Cys Asp 
1               5   


<210>  28
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 4 and figure 5

<400>  28

Ala Gly Ala Asp Asp 
1               5   


<210>  29
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 4 and figure 5

<400>  29

Ala Gly Ala Glu Asp 
1               5   


<210>  30
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 4 and figure 5

<400>  30

Ala Gly Ala Phe Asp 
1               5   


<210>  31
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 4 and figure 5

<400>  31

Ala Gly Ala Gly Asp 
1               5   


<210>  32
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 4 and figure 5

<400>  32

Ala Gly Ala His Asp 
1               5   


<210>  33
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 4 and figure 5

<400>  33

Ala Gly Ala Ile Asp 
1               5   


<210>  34
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 4 and figure 5

<400>  34

Ala Gly Ala Lys Asp 
1               5   


<210>  35
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 4 and figure 5

<400>  35

Ala Gly Ala Leu Asp 
1               5   


<210>  36
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 4 and figure 5

<400>  36

Ala Gly Ala Met Asp 
1               5   


<210>  37
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 4 and figure 5

<400>  37

Ala Gly Ala Asn Asp 
1               5   


<210>  38
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 4 and figure 5

<400>  38

Ala Gly Ala Pro Asp 
1               5   


<210>  39
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 4 and figure 5

<400>  39

Ala Gly Ala Gln Asp 
1               5   


<210>  40
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 4 and figure 5

<400>  40

Ala Gly Ala Arg Asp 
1               5   


<210>  41
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 4 and figure 5

<400>  41

Ala Gly Ala Ser Asp 
1               5   


<210>  42
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 4 and figure 5

<400>  42

Ala Gly Ala Val Asp 
1               5   


<210>  43
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 4 and figure 5

<400>  43

Ala Gly Ala Trp Asp 
1               5   


<210>  44
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 4 and figure 5

<400>  44

Ala Gly Ala Tyr Asp 
1               5   


<210>  45
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 4 and figure 5

<400>  45

Ala Gly Ala Thr Asp 
1               5   


<210>  46
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 4 and figure 5

<400>  46

Ala Gly Cys Thr Asp 
1               5   


<210>  47
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 4 and figure 5

<400>  47

Ala Gly Asp Thr Asp 
1               5   


<210>  48
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 4 and figure 5

<400>  48

Ala Gly Glu Thr Asp 
1               5   


<210>  49
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 4 and figure 5

<400>  49

Ala Gly Gly Thr Asp 
1               5   


<210>  50
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 4 and figure 5

<400>  50

Ala Gly His Thr Asp 
1               5   


<210>  51
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 4 and figure 5

<400>  51

Ala Gly Ile Thr Asp 
1               5   


<210>  52
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 4 and figure 5

<400>  52

Ala Gly Lys Thr Asp 
1               5   


<210>  53
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 4 and figure 5

<400>  53

Ala Gly Leu Thr Asp 
1               5   


<210>  54
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 4 and figure 5

<400>  54

Ala Gly Met Thr Asp 
1               5   


<210>  55
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 4 and figure 5

<400>  55

Ala Gly Asn Thr Asp 
1               5   


<210>  56
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 4 and figure 5

<400>  56

Ala Gly Pro Thr Asp 
1               5   


<210>  57
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 4 and figure 5

<400>  57

Ala Gly Gln Thr Asp 
1               5   


<210>  58
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 4 and figure 5

<400>  58

Ala Gly Arg Thr Asp 
1               5   


<210>  59
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 4 and figure 5

<400>  59

Ala Gly Ser Thr Asp 
1               5   


<210>  60
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 4 and figure 5

<400>  60

Ala Gly Thr Thr Asp 
1               5   


<210>  61
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  table 4 and figure 5

<400>  61

Ala Gly Val Thr Asp 
1               5   


<210>  62
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  figure 4

<400>  62

Asp Thr Ser Asp 
1               


